Stability of atrial sensing and pacing after dual chamber pulse generator implantation  by Klementowicz, Peter T. & Furman, Seymour
1338 
CARDIAC PACING 
JACC Vol. 6, No.6 
December 1985:1338-41 
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Bronx, New York 
The continued efQcacy of dual chamber pacing is pred•
icated on the stability of both atrial and ventricular elec•
trodes. The introduction of the tined atrial J lead has 
decreased the incidence of atrial lead dislodgment, al•
lowing for continued effective sensing and pacing. To 
study the evolution of atrial pacing and sensing thresh•
old, 54 patients with identical pulse generators and atrial 
electrodes were evaluated for 58 ± 29 weeks (mean ± 
SD). 
Immediately after pacemaker implantation in 39 pa•
tients, the amplitude of the atrial signal was measured 
by programming the pulse generator to the lowest sen•
sitivity that assured pacing in the atrial synchronous 
mode. Three levels of atrial sensing were possible: high 
(0.5 mY), intermediate (1.3 mY) and low (2.5 mY) sen•
sitivity. Three patients had a high, 16 patients had a 
medium and 20 patients had a low atrial sensitivity. The 
P wave amplitude and slew rate measured on a physi•
ologic recorder did not differ significantly between the 
latter two grOl.JPs. 
The atrial charge threshold increased from 1.8 ± 1.3 
Dual chamber pacemaker operation requires adequate atrial 
sensing and pacing. With toe advent of the tined atrial J 
electrode, the rate of lead dislodgment has decreased and 
the likelihood of continued effective atrial sensing and pac•
ing has increased (1-5). Soon after implantation of the elec•
trode, an inflammatory response encapsulates the lead tip 
(6). This fibrous reaction secures the electrode to the en•
docardium, changes the pacing threshold and alters the con•
figuration of the endocardial electrogram. To document the 
evolution of the atrial pacing and sensing thresholds, we 
evaluated 54 patients in whom a dual chamber pulse gen•
erator and atrial electrode, identical in type, were implanted. 
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microcoulombs (/-tC) to a maximal value of 2.5 ± 1.3 
/-tC, 3 days to 1 week after implantation (p = 0.02). 
This remained elevated for 1 to 3 months (p = 0.05) 
and then decreased, remaining stable over the ensuing 
year. The atrial sensitivity for the group with non il1-
vasive measurement did not change significantly, al•
though there was considerable patient variation. For 
54% of the patients, atrial sensing remaine~ stable or 
improved. In 26% of the patients, further programming 
to higher sensitivity settings was required. In the re•
maining 20% of the patients, the atrial sensitivity setting 
fluctuated. 
The atrial charge threshold increases in the early 
postoperative period and remains elevated for months. 
The atrial sensing threshold does not follow a predictable 
time course. Although there is little variation in the mean 
size of the atrial electrogram, atrial sensing must be 
continuously monitored to compensate for individual 
fluctuation in the stability of the atrial signal. 
(J Am Coll CardioI1985;6:1338..:...tl) 
Methods 
Implantation technique and measurements. Fifty-four 
patients underwent implantation of a dual chamber pulse 
generator having identical sensing circuitry and identical 
output characteristics and leads with similar electrical char•
acteristics. The leads were inserted in the standard manner 
either through the right subclavian vein or right cephalic 
vein. Using fluoroscopic guidance the atrial lead was po•
sitioned in the right atrial appendage. At the time of im•
plantation, the stimulation threshold was determined at a 
0.5 ms pulse duration using a custom devi~e capable of 
delivering current in increments of 0.01 rnA and voltage in 
increments of 0.01 V. The threshold was determined by 
decreasing the output until capture no longer occurred. The 
impedance was measured at a constant current pulse duration 
of 1.0 ms and an output of 10 rnA. 
Endocardial electrograms were recorded on photo•
graphic paper with a physiologic recorder (Electronics For 
Medicine) at 200 mmls with a pass band of 0.1 to 2,000 
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Hz. The peak to peak amplitude and slew rate were deter•
mined as previously described (7,8). The atrial electrode 
was secured when the implanting physician was satisfied 
with the position of the lead, the stimulation thresholds and 
amplitude and the slew rate and configuration of the 
electrogram. 
Generators and electrodes. All 54 patients (27 men 
and 27 women, mean age 67 ± 13 years) received a similar 
Cordis atrial J electrode (model 327-745 or 327-752). This 
tined electrode has a porous platinum iridium tip, with a 
surface area of 17.6 mm". The conductor is cobalt nickel 
insulated with polyurethane. The 327-745 model is 45 cm 
in length and the 327-752 model is 7 cm longer. Forty•
seven patients received the longer lead. A dual chamber 
pulse generator (Cordis Corporation, model 233F) was im•
planted in 20 patients and model415A in 34 patients. These 
pulse generators have identical sensing and pacing circuitry 
that allows for the selection of discrete pulse width-current 
output combinations and sensing values (Table I). There 
are eight output selections but only three sensitivity settings: 
high (0.5 mY), intermediate (1.3 mY) and low (2.5 mY). 
Follow-up evaluation. After implantation. all 54 pa•
tients were evaluated in the pacemaker clinic. During each 
visit the atrial pacing threshold was determined by pro•
gramming to the lowest pulse width-current output com•
bination that assured atrial capture. The charge threshold 
was calculated by mUltiplying the pulse width by the current 
output. The result is expressed in microcoulombs (p.e). The 
atrial sensitivity was determined by evaluating atrial track•
ing on 2 minute rhythm strips. The lowest sensitivity setting 
that demonstrated continuous atrial sensing was considered 
the sensitivity threshold. 
Statistical analysis. Statistical analysis was performed 
using the Student's t test, and a probability (p) value of less 
than 0.05 was considered significant. 
Results 
The indication for pacing was symptomatic-acquired heart 
block in 28 patients and sinus node dysfunction in 24 pa•
tients. One patient had a documented period of atrial and 
Table 1. Programmable Values for Models 233F and 415A 
Dual Chamber Pulse Generators 
Pulse DurationlOutput Current 
(ms/mA) 
0.2/2 
0.313 
0.414 
0.5/5 
0.6/6 
O.XIB 
1.0110 
2.0/12 
Sensitivity (mY) 
0.5 
U 
2.5 
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ventricular asystole and one patient had an atrioventricular 
(A Y) node ablation for recurrent supraventricular tachycardia. 
Initial implant data. At the time of implantation the P 
wave amplitude was 3.9 ± 2.7 mY (mean ± SD) and the 
slew rate was 2.0 ± 1.8 mY/ms. The pacing threshold 
determined at a pulse duration of 0.5 ms was 2.5 ± 0.9 
rnA and 1.0 ± 0.3 Y. The mean impedance was 380 ± 
50 n. There was no statistical difference in the size of the 
P wave, slew rate, impedance or stimulation threshold when 
comparing those patients with heart block and those with 
sinus dysfunction. 
Immediately after implantation of the pulse generator in 
39 patients, the size of the atrial signal was assessed by 
programming the generator to the lowest sensitivity setting 
that assured atrial tracking. In 3 patients the sensitivity 
threshold was high (0.5 mY), in 16 it was intermediate (1.3 
mY) and in 20 it was low (2.5 mY). The measured P wave 
amplitude was 3.6 ± 3.9 mY and the slew rate was 2.0 ± 
2.6 mY/ms in patients whose sensitivity threshold was 1.3 
mY. For patients with a 2.5 mY sensitivity threshold, the 
P wave amplitude was 3.9 ± 2.2 mY and the slew rate was 
2.5 ± 1.5 mY/ms. These results are not statistically dif•
ferent. The mean sensitivity threshold for patients with sinus 
node dysfunction was 1.8 ± 0.6 mY and this did not differ 
from the mean threshold for those with heart block (I .9 ± 
0.7 mY). 
Follow-up. The mean duration of follow-up for the 54 
patients was 58 ± 29 weeks. All patients remained with 
the dual chamber (DOD) mode and there were no atrial lead 
dislodgments. The initial mean charge threshold for the 
group was 1.8 ± 1.3 p.C, which increased to a maximal 
value of 2.5 ± 1.3 p.C after 3 days to I week (p = 0.02). 
The mean group charge threshold (Fig. 1) remained elevated 
for I to 3 months (p = 0.05); it subsequently decreased 
and was stable over the ensuing year. The maximal atrial 
charge threshold was 6.4 p.C; this was well below the pulse 
generator's highest output of 24 p.c. 
Figure 1. Charge threshold, expressed in microcoulombs (p,C), 
as determined at time intervals after implantation. The number of 
patients evaluated at each time interval is in parentheses. * = 
compared with day 0 to I (p = 0.02); ** = compared with day 
o to 1 (p = 0.05). 
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The mean atrial signal for the group (Fig. 2), measured 
in millivolts by programming the sensitivity of the gener•
ator, did not change significantly over a 1 year period vary•
ing from 1.6 ± 0.8 to 2.0 ± 0.6 mY. Thirty-five percent 
of the patients had a stable atrial sensing threshold; sensing 
improved in 19% of the patients and deteriorated in 26%. 
In the remaining 20%, the atrial signal fluctuated and re•
programming allowed continued atrial sensing. A deterio•
rating or fluctuating atrial sensing threshold was not asso•
ciated with an increasing pacing threshold. 
Discussion 
The introduction of the tined atrial J lead has greatly 
improved the stability of atrial pacing and sensing (1-5). 
Kleinert et al. (5) reported a 6% dislodgment rate in 53 
patients with an implanted tined atrial J lead. Similarly, 
Citron et al. (2) reported a 7% dislodgment rate. Our ex•
perience with the Cordis porous-tipped atrial J lead has been 
equally encouraging. We evaluated 54 patients with an iden•
tical implanted electrode followed up over a 1 year period 
and did not encounter any atrial lead displacement. Atrial 
pacing and sensing were satisfactory and all patiertts re•
mained in the DDD mode. 
Implantation data. The mean P wave amplitude deter•
mined at the time of implantation was 3.9 m V. This does 
not differ greatly from the results previously reported from 
this laboratory (8). Although the size of the endocardial 
signal is influenced by the electrode impedance (9), elec•
trode size and composition (10), the P wave size we ob•
served is compatible with that reported by other investi•
gators. Griffin (4) analyzed the P wave amplitude recorded 
from 10 patients and noted that the mean P wave size was 
3.7 mY. Kruse et al. (3) studied 17 patients and reported 
identical results. Kleinert et al. (5), however, reported a 
larger mean P wave amplitude (5.17 mY). 
Immediately after pacemaker implantation, we measured 
Figure 2. Atrial sensing threshold, expressed in millivolts (mY), 
as determined at time intervals after implantation. The number of 
patients is indicated in the parentheses. 
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the atrial sensitivity in 39 of 54 patients. In 36 of those 
tested (92%), the pacemaker was capable of sensing at either 
a medium (1.3 mY) or a low (2.5 mY) atrial sensitivity. 
The mean P wave amplitude was 3.6 m V for patients whose 
atrial sensitivity was 1.3 mV and did not differ significantly 
from the mean P wave size of patients requiring a lower 
sensitivity. This result is not entirely surprising because the 
Cordis model 233F' or 415A sensing amplifier does not 
discriminate P waves by amplitude alone. The amplifier is 
calibrated to a nonphysiologic signal, rectangular voltage 
step, and the tolerance is wide (11). The endocardial signal 
that the pulse generator detects is not identical to that dis•
played on the physiologic recorder. The signal that the gen•
erator detects is distorted by the generator input impedance 
that filters the signal and attenuates its amplitude (9,12) and 
only the portion of the recorded electrogram that has an 
adequate slew rate is sensed. 
Stability of atrial sensing and pacing. A number of 
investigators (13-16) reported that the ventricular pacing 
threshold increases soon after implantation of the electrode. 
The evolution of the atrial pacing threshold is less well 
characterized. Kruse et al. (3) demonstrated in seven pa•
tients that the atrial voltage threshold measured at constant 
pulse duration continues to increase 4 weeks after implan•
tation. Henglein et al. (13), who studied a pediatric group, 
reported that the atrial pulse width threshold measured at 
constant voltage increased during the early postoperative 
period. In both these studies the patient group was small 
and statistical analysis did not support these threshold trends. 
We studied 54 patients who had an identical pulse generator 
and lead system implanted and demonstrated that the atrial 
pacing charge threshold matures with time. The atrial charge 
threshold increases to a maximum 3 days to 1 week after 
implantation and then decreases modestly during the ensuing 
1 to 3 months. The long-term charge threshold measured 4 
months after implantation is stable and comparable with that 
measured at the time of implantation. The acute increase in 
pacing threshold is believed to occur in response to an in•
flammatory reaction evoked by the electrode (6). 
Although the atrial charge threshold did increase by ap•
proximately 40% during the early postoperative period, the 
size of the atrial electrogram assessed by noninvasive means 
did not. The m'ean size of the atrial signal varied from 1.6 
to 2.0 mV (p = NS) and the majority of patients continued 
to have either medium or low sertsitivity settings. For 54% 
of the patients atrial sensing either remained stable or im•
proved. In 26% of the patients further programming to higher 
sensitivity was required. In the remaining 20% of the pa•
tients, the atrial sensitivity setting fluctuated . 
Clinical implications. There is a predictable increase in 
the atrial charge threshold soon after implantation of the 
atrial electrode. The elevated threshold persists for several 
months. To ensure an adequate margin of safety for atrial 
pacing, the output of the pulse generator must be appro-
lACC Vol. 6, NO.6 
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priately programmed to compensate for the expected in•
crease in pacing threshold, As the lead matures, the pacing 
threshold decreases and the pulse generator can be repro•
grammed to a lower value to maximize longevity, Atrial 
sensing, in marked contradistinction, does not follow a pre•
dictable time course, Although there is little variation in the 
size of the atrial electrogram, atrial sensing must be con•
tinually monitored to compensate for individual fluctuations 
in the stability of the atrial signal. 
References 
I. Messenger JC, Castellanet Ml, Stephenson NL. New pennanent en•
docardial atrial 1 lead: implantation techniques and clinical perfonn•
ance, PACE 1982;5:767-72. 
2. Citron P, Smyth NPD, Kleinert M, Kahn AR, Clinical experience 
with a new transvenous atrial lead, Chest 1978;63: 193-7. 
3, Kruse I, Ryden L, Ydse B. Clinical and electrophysiological char•
acteristics of a Ininsvenous atrial lead. Br Heart 1 1979;42:595-602. 
4. Griffin lC. Sensing characteristics of the right atrial appendage elec•
trode, PACE 1983;63:22-5. 
5, Kleinert M, Bock M, Wilheim F. Clinical use of a new transvenous 
atrial lead. Am 1 Cardiol 1972;40:237-46. 
6. Contini C, Papi L, Pesola A, et al. Tissue reaction to intracavity 
KLEMENTOWICZ AND FURMAN 
ATRIAL PACING 
1341 
electrodes: effect of duration and efficiency of unipolar pacing in 
patients with A-V block. 1 Cardiovasc Surg 1973;14:282-90. 
7. Furman S, Hurzeler P, DeCaprio V. The ventricular endocardial elec•
trogram and pacemaker sensing. 1 Thorac Cardiovasc Surg 
1977;73:258-66. 
8. Funnan S, Hurzeler P, DeCaprio V. Cardiac pacing and pacemakers 
III. Sensing the cardiac electrogram. Am Heart J 1977;93:794-801. 
9. Amundson DC. Sensing properties of pacemaker electrodes. Proc Eng 
Med Bioi 1975;17:83. 
10. Irnich W. Comparison of pacing electrodes of different shape and 
material-recommendations. PACE 1983;6:422-6. 
II. Instructions for Use: Cordis Model415A Gemini Theta. Miami: Cordis 
Corporation, August 1983. 
12. Raber NB, Cuddy TE, Israel DA. Pacemaker electrodes act as high•
pass filters on the electrogram. In: Watanabe Y, ed. Proceedings of 
the Fifth International Symposium. Amsterdam: Excerpta Medica, 
1977: 506-9. 
13. Henglein D, Gillette PC, Shannon C, Bums G. Long-tenn follow-up 
of pulse width threshold of transvenous and myo-epicardial leads. 
PACE 1984;7:203-14. 
14. Grendahl H, Schaaning CG. Variation in pacing threshold. Acta Med 
Scand 1970; 187:75-8. 
15. Westerholm Cl. Threshold studies in transvenous cardiac pacemaker 
treatment. Scand 1 Thorac Cardiovasc Surg 1971;S(suppl 8):1-35. 
16. Luceri RM, Funnan S, Hurzeler p, Escher DIW. Threshold behavior 
of electrodes in long-tenn ventricular pacing. Am 1 Cardiol 
1977;40: 184-8. 
